UC team first in world to achieve complete remission of aggressive pituitary tumor through immunotherapy
May 4, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center were the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The case of the complete remission, which had been previously published in the Neurosurgery Journal, was verified as the first in the world with a novel immunotherapy regimen detailed in a new publication in the journal Surgical Neurology International.